Independent role of p38 and ERK1/2 mitogen-activated kinases in the upregulation of matrix metalloproteinase-1

Experimental Cell Research

Volumn 258, Issue 1, 2000, Pages 135-144

  Brauchle, Maria ^a   Glück, Dorothea ^a   Di Padova, Franco ^a   Han, Jiahuai ^b   Gram, Hermann ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

MAP kinases; MMP 1; MMP 1 promoter activation; mRNA stability

Indexed keywords

COLLAGENASE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGENIC AGENT; SYNAPTOPHYSIN;

ARTICLE; CONTROLLED STUDY; FIBROBLAST CULTURE; GENE INDUCTION; HUMAN; HUMAN CELL; INFLAMMATION; MOLECULAR STABILITY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

EID: 0342757877     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.2000.4913     Document Type: Article

References (52)

1. Woessner J. F. The matrix metalloproteinase family. Parks W. C., Mecham R. P. Matrix Metalloproteinases. 1998;1-14 Academic Press, San Diego.
2. Shapiro S. D. Matrix metalloproteinase degradation of extracellular matrix: Biological consequences. Curr. Opin. Cell. Biol. 10:1998;602-608.
3. Vincenti M. P., White L. A., Schroen D. J., Benbow U., Brinckerhoff C. E. Regulating expression of the gene for matrix metalloproteinase-1 (collagenase): Mechanisms that control enzyme activity, transcription, and mRNA stability. Crit. Rev. Eukaryot. Gene Expr. 6:1996;391-411.
4. Benbow U., Brinckerhoff C. E. Matrix Biol. 15:1997;519-526.
5. Edwards D. R., Murphy G., Reynolds J. J., Whitham S. E., Docherty A. J., Angel P., Heath J. K. Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J. 6:1987;1899-1904.
6. Rutter J. L., Benbow U., Coon C. I., Brinckerhoff C. E. Cell-type specific regulation of human interstitial collagenase-1 gene expression by interleukin-1 beta (IL-1 beta) in human fibroblasts and BC-8701 breast cancer cells. J. Cell. Biochem. 66:1997;322-336.
7. Dayer J. M., Beutler B., Cerami A. Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts. J. Exp. Med. 162:1985;2163-2168.
8. Waskiewicz A. J., Cooper J. A. Mitogen and stress response pathways: MAP kinase cascades and phosphatase regulation in mammals and yeast. Curr. Opin. Cell. Biol. 7:1995;798-805.
9. Robinson M. J., Cobb M. H. Mitogen-activated protein kinase pathways. Curr. Opin. Cell. Biol. 9:1997;180-186.
10. Saklatvala J., Dean J., Finch A. Protein kinase cascades in intracellular signaling by interleukin-1 and tumor necrosis factor. Biochem. Soc. Symp. 64:1999;63-77.
11. Widmann C., Gibson S., Jarpe M. B., Johnson G. L. Mitogen-activated protein kinase: Conservation of a three-kinase module from yeast to human. Physiol. Rev. 79:1999;143-180.
12. Zhou G., Bao Z. Q., Dixon J. E. Components of a new human protein kinase signal transduction pathway. J. Biol. Chem. 270:1995;12665-12669.
13. Watts R. G., Huang C., Young M. R., Li J. J., Dong Z., Pennie W. D., Colburn N. H. Expression of dominant negative Erk2 inhibits AP-1 transactivation and neoplastic transformation. Oncogene. 17:1998;3493-3498.
14. Ridley S. H., Sarsfield S. J., Lee J. C., Bigg H. F., Cawston T. E., Taylor D. J., DeWitt D. L., Saklatvala J. Actions of IL-1 are selectively controlled by p38 mitogen-activated protein kinase: Regulation of prostaglandin H synthase-2, metalloproteinases, and IL-6 at different levels. J. Immunol. 158:1997;3165-3173.
15. Reunanen N., Westermarck J., Hakkinen L., Holmstrom T. H., Elo I., Eriksson J. E., Kahari V. M. Enhancement of fibroblast collagenase (matrix metalloproteinase-1) gene expression by ceramide is mediated by extracellular signal-regulated and stress-activated protein kinase pathways. J. Biol. Chem. 273:1998;5137-5145.
16. Westermarck J., Holmstrom T., Ahonen M., Eriksson J. E., Kahari V. M. Enhancement of fibroblast collagenase-1 (MMP-1) gene expression by tumor promoter okadaic acid is mediated by stress-activated protein kinases Jun N-terminal kinase and p38. Matrix Biol. 17:1998;547-557.
17. Werner S., Peters K. G., Longaker M. T., Fuller-Pace F., Banda M. J., Williams L. T. Large induction of keratinocyte growth factor expression in the dermis during wound healing. Proc. Natl. Acad. Sci. USA. 89:1992;6896-6900.
18. Hla T., Neilson K. Human cyclooxygenase-2 cDNA. Proc. Natl. Acad. Sci. USA. 89:1992;7384-7388.
19. Angel P., Baumann I., Stein B., Delius H., Rahmsdorf H. J., Herrlich P. 12-O-Tetradecanoyl-phorbol-13-acetate induction of the human collagenase gene is mediated by an inducible enhancer element located in the 5′-flanking region. Mol. Cell. Biol. 7:1987;2256-2266.
20. Zhao M., New L., Kravchenko V. V., Kato Y., Gram H., Di Padova F., Olson E. N., Ulevitch R. J., Han J. Regulation of the MEF2 family of transcription factors by p38. Mol. Cell. Biol. 19:1999;21-30.
21. Jiang Y., Gram H., Zhao M., New L., Gu J., Feng L., Di Padova F., Ulevitch R. J., Han J. Characterization of the structure and function of the fourth member of p38 group mitogen-activated protein kinases, p38delta. J. Biol. Chem. 272:1997;30122-30128.
22. Han J., Wang X., Jiang Y., Ulevitch R. J., Lin S. Identification and characterization of a predominant isoform of human MKK3. FEBS Lett. 403:1997;19-22.
23. Lin A., Minden A., Martinetto H., Claret F. X., Lange-Carter C., Mercurio F., Johnson G. L., Karin M. Identification of a dual specificity kinase that activates the Jun kinases and p38-Mpk2. Science. 268:1995;286-290.
24. Ichijo H., Nishida E., Irie K., ten Dijke P., Saitoh M., Moriguchi T., Takagi M., Matsumoto K., Miyazono K., Gotoh Y. Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science. 275:1997;90-94.
25. Derijard B., Hibi M., Wu I. H., Barrett T., Su B., Deng T., Karin M., Davis R. J. JNK1: A protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell. 76:1994;1025-1037.
26. Sluss H. K., Barrett T., Derijard B., Davis R. J. Signal transduction by tumor necrosis factor mediated by JNK protein kinases. Mol. Cell. Biol. 14:1994;8376-8384.
27. Wang Y., Huang S., Sah V. P., Ross J. Jr., Brown J. H., Han J., Chien K. R. Cardiac muscle cell hypertrophy and apoptosis induced by distinct members of the p38 mitogen-activated protein kinase family. J. Biol. Chem. 273:1998;2161-2168.
28. Gupta S., Campbell D., Derijard B., Davis R. J. Transcription factor ATF2 regulation by the JNK signal transduction pathway. Science. 267:1995;389-393.
29. Pierce R. A., Sandefur S., Doyle G. A., Welgus H. G. Monocytic cell type-specific transcriptional induction of collagenase. J. Clin. Invest. 97:1996;1890-1899.
30. Alessi D. R., Cuenda A., Cohen P., Dudley D. T., Saltiel A. R. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J. Biol. Chem. 270:1995;27489-27494.
31. DeSilva D. R., Jones E. A., Favata M. F., Jaffee B. D., Magolda R. L., Trzaskos J. M., Scherle P. A. Inhibition of mitogen-activated protein kinase kinase blocks T cell proliferation but does not induce or prevent anergy. J. Immunol. 160:1998;4175-4181.
32. Favata M. F., Horiuchi K. Y., Manos E. J., Daulerio A. J., Stradley D. A., Feeser W. S., Van Dyk D. E., Pitts W. J., Earl R. A., Hobbs F., Copeland R. A., Magolda R. L., Scherle P. A., Trzaskos J. M. Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J. Biol. Chem. 273:1998;18623-18632.
33. Cuenda A., Rouse J., Doza Y. N., Meier R., Cohen P., Gallagher T. F., Young P. R., Lee J. C. SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett. 364:1995;229-233.
34. Clerk A., Sugden P. H. The p38-MAPK inhibitor, SB203580, inhibits cardiac stress-activated protein kinases/c-Jun N-terminal kinases (SAPKs/JNKs). FEBS Lett. 426:1998;93-96.
35. Tan Y., Rouse J., Zhang A., Cariati S., Cohen P., Comb M. FGF and stress regulate CREB and ATF-1 via a pathway involving p38 MAP kinase and MAPKAP kinase-2. EMBO J. 15:1996;4629-4642.
36. Minden A., Lin A., Smeal T., Derijard B., Cobb M., Davis R., Karin M. c-Jun N-terminal phosphorylation correlates with activation of the JNK subgroup but not the ERK subgroup of mitogen-activated protein kinases. Mol. Cell. Biol. 14:1994;6683-6688.
37. Xing J., Ginty D. D., Greenberg M. E. Coupling of the RAS-MAPK pathway to gene activation by RSK2, a growth factor-regulated CREB kinase. Science. 273:1996;959-963.
38. Zhao Y., Bjorbaek C., Moller D. E. Regulation and interaction of pp90(rsk) isoforms with mitogen-activated protein kinases. J. Biol. Chem. 271:1996;29773-29779.
39. Vincenti M. P., Coon C. I., Lee O., Brinckerhoff C. E. Regulation of collagenase gene expression by IL-1 beta requires transcriptional and post-transcriptional mechanisms. Nucleic Acids Res. 22:1994;4818-4827.
40. Aho S., Rouda S., Kennedy S. H., Qin H., Tan E. M. Regulation of human interstitial collagenase (matrix metalloproteinase-1) promoter activity by fibroblast growth factor. Eur. J. Biochem. 247:1997;503-510.
41. Crews C. M., Alessandrini A., Erikson R. L. The primary structure of MEK, a protein kinase that phosphorylates the ERK gene product. Science. 258:1992;478-480.
42. Derijard B., Raingeaud J., Barrett T., Wu I. H., Han J., Ulevitch R. J., Davis R. J. Independent human MAP-kinase signal transduction pathways defined by MEK and MKK isoforms. Science. 267:1995;682-685.
43. Tournier C., Whitmarsh A. J., Cavanagh J., Barrett T., Davis R. J. Mitogen-activated protein kinase kinase 7 is an activator of the c-Jun NH2-terminal kinase. Proc. Natl. Acad. Sci. USA. 94:1997;7337-7342.
44. Lange-Carter C. A., Pleiman C. M., Gardner A. M., Blumer K. J., Johnson G. L. A divergence in the MAP kinase regulatory network defined by MEK kinase and Raf. Science. 260:1993;315-319.
45. Xia Y., Wu Z., Su B., Murray B., Karin M. JNKK1 organizes a MAP kinase module through specific and sequential interactions with upstream and downstream components mediated by its amino-terminal extension. Genes Dev. 12:1998;3369-3381.
46. Yujiri T., Sather S., Fanger G. R., Johnson G. L. Role of MEKK1 in cell survival and activation of JNK and ERK pathways defined by targeted gene disruption. Science. 282:1998;1911-1914.
47. Ridley S. H., Dean J. L., Sarsfield S. J., Brook M., Clark A. R., Saklatvala J. A p38 MAP kinase inhibitor regulates stability of interleukin-1-induced cyclooxygenase-2 mRNA. FEBS Lett. 439:1998;75-80.
48. Miyazawa K., Mori A., Miyata H., Akahane M., Ajisawa Y., Okudaira H. Regulation of interleukin-1beta-induced interleukin-6 gene expression in human fibroblast-like synoviocytes by p38 mitogen-activated protein kinase. J. Biol. Chem. 273:1998;24832-24838.
49. Fini M. E., Plucinska I. M., Mayer A. S., Gross R. H., Brinckerhoff C. E. A gene for rabbit synovial cell collagenase: Member of a family of metalloproteinases that degrade the connective tissue matrix. Biochemistry. 26:1987;6156-6165.
50. Lawler S., Fleming Y., Goedert M., Cohen P. Synergistic activation of SAPK1/JNK1 by two MAP kinase kinases in vitro. Curr. Biol. 8:1998;1387-1390.
51. Kumar S., McDonnell P. C., Gum R. J., Hand A. T., Lee J. C., Young P. R. Novel homologues of CSBP/p38 MAP kinase: Activation, substrate specificity and sensitivity to inhibition by pyridinyl imidazoles. Biochem. Biophys. Res. Commun. 235:1997;533-538.
52. Winzen R., Kracht M., Ritter B., Wilhelm A., Chen C. Y., Shyu A. B., Muller M., Gaestel M., Resch K., Holtmann H. The p38 MAP kinase pathway signals for cytokine-induced mRNA stabilization via MAP kinase-activated protein kinase 2 and an AU-rich region-targeted mechanism. EMBO J. 18:1999;4969-4980.